BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9795237)

  • 1. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system.
    Pestonjamasp VK; Burstein SH
    Biochim Biophys Acta; 1998 Nov; 1394(2-3):249-60. PubMed ID: 9795237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis.
    Hunter SA; Burstein SH
    Life Sci; 1997; 60(18):1563-73. PubMed ID: 9126878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
    Anikwue R; Huffman JW; Martin ZL; Welch SP
    J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.
    Eisenstein TK; Meissler JJ; Wilson Q; Gaughan JP; Adler MW
    J Neuroimmunol; 2007 Sep; 189(1-2):17-22. PubMed ID: 17640739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells.
    Berdyshev EV; Boichot E; Germain N; Allain N; Anger JP; Lagente V
    Eur J Pharmacol; 1997 Jul; 330(2-3):231-40. PubMed ID: 9253958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
    Welch SP; Huffman JW; Lowe J
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.
    Varga K; Wagner JA; Bridgen DT; Kunos G
    FASEB J; 1998 Aug; 12(11):1035-44. PubMed ID: 9707176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
    Chang YH; Lee ST; Lin WW
    J Cell Biochem; 2001; 81(4):715-23. PubMed ID: 11329626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
    Paria BC; Ma W; Andrenyak DM; Schmid PC; Schmid HH; Moody DE; Deng H; Makriyannis A; Dey SK
    Biol Reprod; 1998 Jun; 58(6):1490-5. PubMed ID: 9623610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta 9-tetrahydrocannabinol (THC).
    Burstein SH; Hunter SA
    Biochem Pharmacol; 1995 Mar; 49(6):855-8. PubMed ID: 7702643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid.
    Braud S; Bon C; Touqui L; Mounier C
    FEBS Lett; 2000 Apr; 471(1):12-6. PubMed ID: 10760504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental aspects of anandamide: ontogeny of response and prenatal exposure.
    Fride E; Mechoulam R
    Psychoneuroendocrinology; 1996 Feb; 21(2):157-72. PubMed ID: 8774060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin.
    Ellis EF; Moore SF; Willoughby KA
    Am J Physiol; 1995 Dec; 269(6 Pt 2):H1859-64. PubMed ID: 8594893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists.
    Fleming I; Schermer B; Popp R; Busse R
    Br J Pharmacol; 1999 Feb; 126(4):949-60. PubMed ID: 10193775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
    O'Sullivan SE; Kendall DA; Randall MD
    Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells.
    Berdyshev EV; Schmid PC; Krebsbach RJ; Schmid HH
    FASEB J; 2001 Oct; 15(12):2171-8. PubMed ID: 11641243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice.
    Wiley JL; Razdan RK; Martin BR
    Life Sci; 2006 Dec; 80(1):24-35. PubMed ID: 16978656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.